Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Tectonic Therapeutics’s reported figures.
The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212016
FAQ
- What is Tectonic Therapeutics's EBIT?
- Tectonic Therapeutics (TECX) reported EBIT of -$27.3M in Q1 2026.
- How has Tectonic Therapeutics's EBIT changed year-over-year?
- Tectonic Therapeutics's EBIT decreased by 49.2% year-over-year, from -$18.3M to -$27.3M.
- What is the long-term trend for Tectonic Therapeutics's EBIT?
- Over 4 years (2021 to 2025), Tectonic Therapeutics's EBIT has grown at a -8.3% compound annual growth rate (CAGR), from -$118.84M to -$84.04M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Tectonic Therapeutics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude